SoftMedx Completes Scheme Share Issue, Slightly Dilutes Controlling Stake

An announcement from China Wah Yan Healthcare ( (HK:0648) ) is now available.

SoftMedx Healthcare Limited has completed the issuance of new scheme shares under a specific mandate, following the fulfillment of all conditions precedent on 1 April 2026. The transaction modestly increased the company’s total share capital to about 2.14 billion shares and introduced a trustee as a new public shareholder, slightly diluting the controlling stake of Multi Omniverse Group Limited from 74.9% to 74.4% while marginally broadening the public float.

The revised shareholding structure leaves the controlling shareholder’s influence effectively intact but signals a small step toward diversifying ownership through the scheme share arrangement. For minority investors, the change marginally enhances liquidity and public participation in the stock, although governance and strategic control remain firmly in the hands of the dominant shareholder group.

More about China Wah Yan Healthcare

SoftMedx Healthcare Limited, formerly known as China Wah Yan Healthcare, operates in the healthcare sector and is listed on the Hong Kong Stock Exchange. The company’s ownership is highly concentrated, with controlling shareholder Multi Omniverse Group Limited holding roughly three-quarters of its issued share capital, while the remainder is held by public investors, including a trustee structure and other minority shareholders.

Average Trading Volume: 2,239,188

Technical Sentiment Signal: Sell

Current Market Cap: HK$542.1M

See more data about 0648 stock on TipRanks’ Stock Analysis page.